Wanjie Sun
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 7
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 4
-
- Diabetes Management and Research 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Ophthalmology top 5%
- Retinal Diseases and Treatments 5
-
- Statistical Methods in Clinical Trials 15
-
- Optimal Experimental Design Methods 9
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- Patricia A. ClearySaul GenuthJohn M. LachinDavid R. SellVincent M. MonnierBernard ZinmanMichael W. SteffesMark E. Molitch
- Journals
- PLoS ONE (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes Care (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Wanjie Sun
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 106
- Clinical Biochemistry 579
- Nephrology 386
- Endocrinology, Diabetes and Metabolism 837
- Ophthalmology 171
- Cardiology and Cardiovascular Medicine 218
Countries citing papers authored by Wanjie Sun
This map shows the geographic impact of Wanjie Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjie Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjie Sun more than expected).
Fields of papers citing papers by Wanjie Sun
This network shows the impact of papers produced by Wanjie Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjie Sun. The network helps show where Wanjie Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wanjie Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 3 | |
| 3 | 2020 | 10 | |
| 4 | 2019 | 5 | |
| 5 | 2019 | 4 | |
| 6 | 2016 | 21 | |
| 7 | 2015 | 51 | |
| 8 | 2014 | 62 | |
| 9 | 2014 | 182 | |
| 10 | 2014 | 113 | |
| 11 | 2013 | 57 | |
| 12 | Intensive Diabetes Therapy Reduces Ocular Surgeries in Patients with Type 1 Diabetes: twenty-eight year followup of the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC) | 2013 | 2 |
| 13 | 2013 | 38 | |
| 14 | 2013 | 33 | |
| 15 | Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study | 2013 | 3 |
| 16 | 2012 | 44 | |
| 17 | Comparability of Digital vs. Film Grading of Diabetic Retinopathy Severity in DCCT/EDIC | 2010 | 1 |
| 18 | 2006 | 190 | |
| 19 | 2004 | 28 | |
| 20 | 2004 | 32 |
About Wanjie Sun
Wanjie Sun is a scholar working on Statistics and Probability, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (15 papers), Optimal Experimental Design Methods (9 papers), Advanced Glycation End Products research (7 papers), Diabetes Management and Research (6 papers), Retinal Diseases and Treatments (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Clinical Biochemistry (579 citations), Nephrology (386 citations) and Endocrinology, Diabetes and Metabolism (837 citations). Wanjie Sun has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Patricia A. Cleary, Saul Genuth, John M. Lachin, David R. Sell, Vincent M. Monnier, Bernard Zinman, Michael W. Steffes, Mark E. Molitch, Ian H. de Boer and William I. Sivitz. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.